News
-
-
-
-
-
-
-
-
PRESS RELEASE
New to The Street Client NRx Pharmaceuticals (NASDAQ:NRXP) Secures FDA Fast Track Designation for NRX-100, Expanding Reach to 13 Million Americans Confronting Suicidal Ideation
NRx Pharmaceuticals receives FDA Fast Track Designation for NRX-100 in treating suicidal ideation in depression, expanding patient population and addressing unmet medical needs -
-